Concepedia

M. Gershanovich

MG

Statistics

Publications

8

Citations

649

H-Index

8

Active since

1993

Affiliations

Institute of Oncology NN Petrov(Current)

Novartis (Switzerland)

Orion Corporation (Finland)

M. Gershanovich is an author at Institute of Oncology NN Petrov specializing in medicine, oncology, and pharmacology.

Publications per year

1993–2004

8

Publications

8

Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer

M. Gershanovich, H.A. Chaudri, H. Lurie et al. · Annals of Oncology · 1998 · 263 citations · Full text

Medicine, Oncology, Pharmacology +15

An open randomised trial of second-line endocrine therapy in advanced breast cancer

Carsten Rose, O. Vtoraya, A Płużańska et al. · European Journal of Cancer · 2003 · 192 citations

Medicine, Endocrinology, Oncology +13

A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer

M. Gershanovich, August Garin, Dace Baltina et al. · Breast Cancer Research and Treatment · 1997 · 79 citations

Medicine, Oncology, Pharmacology +14

Superiority of Letrozole to Tamoxifen in the First-Line Treatment of Advanced Breast Cancer: Evidence from Metastatic Subgroups and a Test of Functional Ability

Henning T. Mouridsen, Yuxiu Sun, M. Gershanovich et al. · The Oncologist · 2004 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children

M. Gershanovich, Boris A. Kolygin, N. Pirgach · Annals of Oncology · 1993 · 21 citations · Full text

Medicine, Oncology, Pharmacology +12

1–5 of 8